Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreased glucagon-like peptide 1 fasting levels in type 2 diabetes.

× No keyword cloud information.

11 in total

1. Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles.

Authors: Wakaya Fujiwara; Hideo Izawa; Gen Ukai; Hiroatsu Yokoi; Daisuke Mukaide; Kohsuke Kinoshita; Shin-ichiro Morimoto; Junichi Ishii; Yukio Ozaki; Masanori Nomura
Journal: Heart Vessels Date: 2012-03-25 Impact factor: 2.037

Review 2. Coming full circle in diabetes mellitus: from complications to initiation.

Authors: Brooke E Harcourt; Sally A Penfold; Josephine M Forbes
Journal: Nat Rev Endocrinol Date: 2013-01-08 Impact factor: 43.330

3. Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms.

Authors: Marion L Vetter; Scott Ritter; Thomas A Wadden; David B Sarwer
Journal: Diabetes Spectr Date: 2012-11-01

4. The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus.

Authors: Agus Lastya; Made Ratna Saraswati; Ketut Suastika
Journal: BMC Res Notes Date: 2014-11-26

5. Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects.

Authors: Radwan H Ahmed; Hasniza Zaman Huri; Zaid Al-Hamodi; Sameer D Salem; Sekaran Muniandy
Journal: PLoS One Date: 2015-10-16 Impact factor: 3.240

6. Positive correlation of PTH-related peptide with glucose in type 2 diabetes.

Authors: Ioannis Legakis; Timos Mantouridis
Journal: Exp Diabetes Res Date: 2009-08-31

7. Analysis of patient-specific factors contributing to effectiveness of glucagon-like peptide-1 receptor agonists.

Authors: Kelly A Mazzei; Ashley N Trippett; Teresa D Hedrick; Sijin Wen
Journal: J Am Pharm Assoc (2003) Date: 2020-08-08

Review 8. Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1.

Authors: XingChun Wang; Huan Liu; Jiaqi Chen; Yan Li; Shen Qu
Journal: Int J Endocrinol Date: 2015-08-20 Impact factor: 3.257

Review 9. Safety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitus.

Authors: Chitrabhanu Ballav; Stephen C L Gough
Journal: Clin Med Insights Endocrinol Diabetes Date: 2013-09-01

10. Accumulation of intestinal tissue 3-deoxyglucosone attenuated GLP-1 secretion and its insulinotropic effect in rats.

Authors: Lurong Zhang; Xiudao Song; Liang Zhou; Guoqiang Liang; Heng Xu; Fei Wang; Fei Huang; Guorong Jiang
Journal: Diabetol Metab Syndr Date: 2016-11-29 Impact factor: 3.320